Continuous Glucose Monitoring (CGM): From Research to Real-World Application

YEHONATAN RAVENNA, Chemistry, Tingo Medical, לוזית, Israel (yehonatan@tingomedical.com)

Continuous Glucose Monitoring (CGM) systems have revolutionized diabetes management by providing real-time glucose readings, enabling better glycemic control.

This presentation will explore the comprehensive development process of CGM devices, focusing on the critical role of electrochemistry in advancing sensor technology.

Key aspects will include enzyme immobilization strategies for optimal glucose detection, the engineering of glucose-limiting membranes, and the integration of biocompatibility layers to ensure user safety and prolonged sensor function.

The discussion will also cover the challenges and solutions encountered during the transition from academic research to market-ready products, emphasizing the rigorous production processes and regulatory considerations.

The talk aims to provide insights into how electrochemistry can be harnessed to create effective, reliable CGM systems and will emphasize the collaborative efforts between various disciplines that are crucial for turning cutting-edge research into practical tools that improve daily diabetes management

 

---

Short Biography of Presenting Author

 

Yehonatan Ravenna holds a B.Sc. and M.Sc. in Biotechnology Engineering from Ben-Gurion University in Israel, where he conducted research on biosensors and biofuel cells in Prof. Lital Alfonta's lab. With a career spanning roles as an electrochemist at Smartzyme startup and management positions at Intel, Yehonatan transitioned to founding Tingo Medical as its first employee. At Tingo, he established and leads the sensor development, R&D, and production efforts for cutting-edge Continuous Glucose Monitoring (CGM) systems. Under his leadership, Tingo Medical is approaching its third clinical trial after four years of operation, contributing innovative solutions to diabetes management.